• Skip to navigation (Access key ‘n’)
  • Skip to page content (Access key ‘c’)
National Horizon Scanning Centre logoNational Horizon Scanning Centre
University of Birmingham NHS National Institute for Health Research
  • Home
  • About Us
    • Methods
    • Customers & Partners
    • Glossary
    • Governance
    • Related Links
    • Who's Who?
  • Outputs
    • Outputs by Specialty
    • Research & Publications
    • Other Reports
  • News
  • Suggest a topic
  • Contact Us

More Search Options

Filtering options e.g. by technology type, and for multiple years are available within the results

Gynaecology, Women's Sexual Health and Benign Breast Disease

Filter topics in this Specialty Topics can be filtered and/or combined by year of entry, technology type, and other specialties

  • Drug Briefings (2)
  • Diagnostic Briefings (5)
  • Device Briefings (0)
  • Other Reports (0)

Bevacizumab (Avastin) for triple negative adjuvant breast cancer; in combination with taxane and/or anthracycline chemotherapy

Date:1 December 2011

Dienogest (Visabelle) for endometriosis, recurrent - second/third line

Date:1 April 2010

HPV OncoTect® E6 E7 mRNA Assay to guide colposcopy referral in cervical cancer screening

Date:1 March 2012

ARCHITECT HE4 assay for disease monitoring in ovarian cancer

Date:1 October 2010

ARCHITECT HE4 assay for risk assessment of ovarian cancer in symptomatic women with an adnexal mass

Date:1 October 2010

Cervista® human papillomavirus 16/18 test for the detection of HPV type 16 and HPV type 18 in cervical samples

Date:1 July 2010

Cervista® Human Papillomavirus High Risk test for the detection of 14 high-risk human papilloma viral types in cervical samples

Date:1 July 2010

NIHR Horizon Scanning Centre, School of Health & Population Sciences, University of Birmingham,
90 Vincent Drive, Edgbaston, Birmingham B15 2SQ
Tel: +44 (0)121 414 7831 Email: nhscadmin@contacts.bham.ac.uk

© University of Birmingham 2000-2012

Made Media Ltd.